The Enterprise Value as of December 2025 (TTM) for Kangmei Pharmaceutical Co., Ltd. (600518.SS) is 25.98B

According to Kangmei Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 25.98B. This represents a change of -8.70% compared to the average of 28.46B of the last 4 quarters.

Kangmei Pharmaceutical Co., Ltd. (600518.SS) Historical Enterprise Value (quarterly & annually)

How has 600518.SS Enterprise Value performed in the past?

The mean historical Enterprise Value of Kangmei Pharmaceutical Co., Ltd. over the last ten years is 57.37B. The current 25.98B Enterprise Value has changed 4.43% with respect to the historical average. Over the past ten years (40 quarters), 600518.SS's Enterprise Value was at its highest in in the December 2017 quarter at 129.81B. The Enterprise Value was at its lowest in in the March 2024 quarter at 15.80B.

Kangmei Pharmaceutical Co., Ltd. (600518.SS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Kangmei Pharmaceutical Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Kangmei Pharmaceutical Co., Ltd. (600518.SS) Average Enterprise Value

How has 600518.SS Enterprise Value performed in the past?

The current Enterprise Value of Kangmei Pharmaceutical Co., Ltd. (600518.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Kangmei Pharmaceutical Co., Ltd. (600518.SS) Enterprise Value vs. Peers

How is 600518.SS’s Enterprise Value compared to its peers?

Kangmei Pharmaceutical Co., Ltd.’s Enterprise Value is less than Zhejiang Huahai Pharmaceutical Co., Ltd. (32.94B), greater than Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (25.98B), greater than Chengdu Kanghong Pharmaceutical Group Co., Ltd (24.72B), greater than Dong-E-E-Jiao Co.,Ltd. (25.91B), greater than Betta Pharmaceuticals Co., Ltd. (21.95B), greater than Jilin Aodong Pharmaceutical Group Co., Ltd. (23.81B), less than Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (28.64B), greater than Jiangsu Nhwa Pharmaceutical Co., Ltd. (24.54B), greater than Livzon Pharmaceutical Group Inc. (25.78B), greater than China National Medicines Corporation Ltd. (16.94B),

Build a custom stock screener for Kangmei Pharmaceutical Co., Ltd. (600518.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kangmei Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kangmei Pharmaceutical Co., Ltd. (600518.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kangmei Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.